
Sarae L. Bausch
Examiner (ID: 9546, Phone: (571)272-2912 , Office: P/1634 )
| Most Active Art Unit | 1634 |
| Art Unit(s) | 1634, 1699 |
| Total Applications | 1025 |
| Issued Applications | 192 |
| Pending Applications | 210 |
| Abandoned Applications | 650 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18452124
[patent_doc_number] => 20230193403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => NOVEL INSECTICIDAL TOXIN RECEPTORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/995246
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13717
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995246
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995246 | NOVEL INSECTICIDAL TOXIN RECEPTORS AND METHODS OF USE | Mar 8, 2021 | Pending |
Array
(
[id] => 17243848
[patent_doc_number] => 20210363591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => MAPK1 MUTATIONS AND DRUG SENSITIVITY
[patent_app_type] => utility
[patent_app_number] => 17/193615
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17193615
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/193615 | MAPK1 MUTATIONS AND DRUG SENSITIVITY | Mar 4, 2021 | Abandoned |
Array
(
[id] => 18321430
[patent_doc_number] => 20230119558
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => DNA DAMAGE REPAIR GENES IN CANCER
[patent_app_type] => utility
[patent_app_number] => 17/909500
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/909500 | DNA DAMAGE REPAIR GENES IN CANCER | Mar 4, 2021 | Pending |
Array
(
[id] => 18319241
[patent_doc_number] => 20230117369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => COMPOSITIONS AND METHODS FOR DETECTING SARS-COV-2 NUCLEAIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/905443
[patent_app_country] => US
[patent_app_date] => 2021-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905443
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905443 | COMPOSITIONS AND METHODS FOR DETECTING SARS-COV-2 NUCLEAIC ACID | Mar 3, 2021 | Pending |
Array
(
[id] => 18271875
[patent_doc_number] => 20230093117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => SYSTEMS AND METHODS FOR THE DETECTION AND TREATMENT OF ASPERGILLUS INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/801724
[patent_app_country] => US
[patent_app_date] => 2021-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27038
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801724
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/801724 | SYSTEMS AND METHODS FOR THE DETECTION AND TREATMENT OF ASPERGILLUS INFECTION | Feb 22, 2021 | Pending |
Array
(
[id] => 18364447
[patent_doc_number] => 20230146038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => DIMERIZATION ASSAY
[patent_app_type] => utility
[patent_app_number] => 17/796156
[patent_app_country] => US
[patent_app_date] => 2021-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29402
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796156
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/796156 | DIMERIZATION ASSAY | Feb 2, 2021 | Abandoned |
Array
(
[id] => 18254490
[patent_doc_number] => 20230081529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => ANALYSIS METHOD FOR INCREASING SUSCEPTIBILITY TO SORAFENIB TREATMENT IN HEPATOCELLULAR CARCINOMA
[patent_app_type] => utility
[patent_app_number] => 17/760411
[patent_app_country] => US
[patent_app_date] => 2021-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17760411
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/760411 | ANALYSIS METHOD FOR INCREASING SUSCEPTIBILITY TO SORAFENIB TREATMENT IN HEPATOCELLULAR CARCINOMA | Jan 31, 2021 | Pending |
Array
(
[id] => 19020571
[patent_doc_number] => 20240076742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => METHODS FOR IMPROVED CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/795312
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795312 | METHODS FOR IMPROVED CANCER TREATMENT | Jan 28, 2021 | Pending |
Array
(
[id] => 18223254
[patent_doc_number] => 20230062248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => METHODS FOR PREDICTING IXABEPILONE RESPONSIVENESS IN CANCER PATIENTS
[patent_app_type] => utility
[patent_app_number] => 17/795428
[patent_app_country] => US
[patent_app_date] => 2021-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 106804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17795428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/795428 | METHODS FOR PREDICTING IXABEPILONE RESPONSIVENESS IN CANCER PATIENTS | Jan 28, 2021 | Abandoned |
Array
(
[id] => 18786470
[patent_doc_number] => 20230374596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => APPLICATION OF RED BLOOD CELL NUCLEIC ACID IN IDENTIFYING TUMOR MUTATION TYPES
[patent_app_type] => utility
[patent_app_number] => 17/913418
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/913418 | APPLICATION OF RED BLOOD CELL NUCLEIC ACID IN IDENTIFYING TUMOR MUTATION TYPES | Jan 27, 2021 | Abandoned |
Array
(
[id] => 18337112
[patent_doc_number] => 20230129061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => The use of growth factor-encoding nucleoside-modified mRNA for periodontal tissue regeneration
[patent_app_type] => utility
[patent_app_number] => 17/759361
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17759361
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/759361 | The use of growth factor-encoding nucleoside-modified mRNA for periodontal tissue regeneration | Jan 21, 2021 | Pending |
Array
(
[id] => 18161314
[patent_doc_number] => 20230027906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => TERT Promoter Droplet Digital PCR Assay for the Diagnosis of Malignant Cancers
[patent_app_type] => utility
[patent_app_number] => 17/781423
[patent_app_country] => US
[patent_app_date] => 2020-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16135
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/781423 | TERT Promoter Droplet Digital PCR Assay for the Diagnosis of Malignant Cancers | Dec 6, 2020 | Abandoned |
Array
(
[id] => 17688247
[patent_doc_number] => 20220195539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => Methods for Detecting Low Levels of Covid-19 Virus
[patent_app_type] => utility
[patent_app_number] => 16/950171
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950171
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950171 | Methods for detecting low levels of COVID-19 virus | Nov 16, 2020 | Issued |
Array
(
[id] => 18005391
[patent_doc_number] => 20220364157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => Methods for Detecting Low Levels of Covid-19 Virus
[patent_app_type] => utility
[patent_app_number] => 16/950210
[patent_app_country] => US
[patent_app_date] => 2020-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46754
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16950210
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/950210 | Methods for Detecting Low Levels of Covid-19 Virus | Nov 16, 2020 | Abandoned |
Array
(
[id] => 18413441
[patent_doc_number] => 11667976
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-06
[patent_title] => TERT promoter mutations in urothelial neoplasia
[patent_app_type] => utility
[patent_app_number] => 17/097510
[patent_app_country] => US
[patent_app_date] => 2020-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 4463
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17097510
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/097510 | TERT promoter mutations in urothelial neoplasia | Nov 12, 2020 | Issued |
Array
(
[id] => 16657830
[patent_doc_number] => 20210054466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => TUMOR BIOMARKERS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/092653
[patent_app_country] => US
[patent_app_date] => 2020-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25125
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17092653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/092653 | TUMOR BIOMARKERS AND USE THEREOF | Nov 8, 2020 | Abandoned |
Array
(
[id] => 18194193
[patent_doc_number] => 20230047712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => Methods of Treatments Based Upon Molecular Response to Treatment
[patent_app_type] => utility
[patent_app_number] => 17/755519
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16908
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755519
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755519 | Methods of Treatments Based Upon Molecular Response to Treatment | Oct 28, 2020 | Pending |
Array
(
[id] => 19158132
[patent_doc_number] => 20240150839
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => METHODS FOR PREDICTING RESPONSIVENESS OF PROSTATE CANCER PATIENTS TO PARP INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/773288
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17773288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/773288 | METHODS FOR PREDICTING RESPONSIVENESS OF PROSTATE CANCER PATIENTS TO PARP INHIBITORS | Oct 28, 2020 | Pending |
Array
(
[id] => 18406149
[patent_doc_number] => 20230167500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => SUDDEN CARDIAC DEATH SUSCEPTIBILITY DETECTION KIT BASED ON INSERTION/DELETION POLYMORPHIC SITE OF COX10 GENE
[patent_app_type] => utility
[patent_app_number] => 17/762065
[patent_app_country] => US
[patent_app_date] => 2020-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1922
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762065
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762065 | SUDDEN CARDIAC DEATH SUSCEPTIBILITY DETECTION KIT BASED ON INSERTION/DELETION POLYMORPHIC SITE OF COX10 GENE | Oct 20, 2020 | Pending |
Array
(
[id] => 17990488
[patent_doc_number] => 20220356525
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS OF DETERMINING WHETHER PATIENTS SUFFERING FROM ACUTE MYELOID LEUKEMIA WILL ACHIEVE A RESPONSE TO AN MYC-TARGETING THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/764642
[patent_app_country] => US
[patent_app_date] => 2020-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17764642
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/764642 | METHODS OF DETERMINING WHETHER PATIENTS SUFFERING FROM ACUTE MYELOID LEUKEMIA WILL ACHIEVE A RESPONSE TO AN MYC-TARGETING THERAPY | Oct 14, 2020 | Abandoned |